59 related articles for article (PubMed ID: 22691704)
1. Preparation and characterization of mouse IL-22 and its four single-amino-acid muteins that act as IL-22 receptor-1 antagonists.
Niv-Spector L; Shpilman M; Levi-Bober M; Katz M; Varol C; Elinav E; Gertler A
Protein Eng Des Sel; 2012 Aug; 25(8):397-404. PubMed ID: 22691704
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of mouse IL-22 binding protein.
Wei CC; Ho TW; Liang WG; Chen GY; Chang MS
Genes Immun; 2003 Apr; 4(3):204-11. PubMed ID: 12700595
[TBL] [Abstract][Full Text] [Related]
4. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
Donaldson DD; Whitters MJ; Fitz LJ; Neben TY; Finnerty H; Henderson SL; O'Hara RM; Beier DR; Turner KJ; Wood CR; Collins M
J Immunol; 1998 Sep; 161(5):2317-24. PubMed ID: 9725226
[TBL] [Abstract][Full Text] [Related]
5. Large-scale preparation and characterization of non-pegylated and pegylated superactive ovine leptin antagonist.
Niv-Spector L; Shpilman M; Boisclair Y; Gertler A
Protein Expr Purif; 2012 Feb; 81(2):186-92. PubMed ID: 22040607
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and identification of recombinant mouse interleukin 21 protein in E. coli.
Tang W; Chen G; Gu Q; Pan J; Wu W
Cell Mol Immunol; 2006 Aug; 3(4):311-5. PubMed ID: 17083198
[TBL] [Abstract][Full Text] [Related]
7. Role of the C-terminus in the activity, conformation, and stability of interleukin-6.
Ward LD; Hammacher A; Zhang JG; Weinstock J; Yasukawa K; Morton CJ; Norton RS; Simpson RJ
Protein Sci; 1993 Sep; 2(9):1472-81. PubMed ID: 8401231
[TBL] [Abstract][Full Text] [Related]
8. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs.
Scott CW; Budzilowicz C; Hubbs SJ; Stein M; Sobotka-Briner C; Wilkins DE
Mediators Inflamm; 2000; 9(3-4):181-7. PubMed ID: 11132776
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway.
Li TS; Li XN; Chang ZJ; Fu XY; Liu L
Cell Signal; 2006 Aug; 18(8):1287-98. PubMed ID: 16310341
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
[TBL] [Abstract][Full Text] [Related]
11. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
Chada S; Mhashilkar AM; Ramesh R; Mumm JB; Sutton RB; Bocangel D; Zheng M; Grimm EA; Ekmekcioglu S
Mol Ther; 2004 Dec; 10(6):1085-95. PubMed ID: 15564140
[TBL] [Abstract][Full Text] [Related]
12. Large-scale preparation of biologically active mouse and rat leptins and their L39A/D40A/F41A muteins which act as potent antagonists.
Salomon G; Niv-Spector L; Gussakovsky EE; Gertler A
Protein Expr Purif; 2006 May; 47(1):128-36. PubMed ID: 16289983
[TBL] [Abstract][Full Text] [Related]
13. Preparation of leptin antagonists by site-directed mutagenesis of human, ovine, rat, and mouse leptin's site III: implications on blocking undesired leptin action in vivo.
Solomon G; Niv-Spector L; Gonen-Berger D; Callebaut I; Djiane J; Gertler A
Ann N Y Acad Sci; 2006 Dec; 1091():531-9. PubMed ID: 17341642
[TBL] [Abstract][Full Text] [Related]
14. A novel transcript of mouse interleukin-20 receptor acts on glomerular mesangial cells as an aggravating factor in lupus nephritis.
Wei CC; Chang MS
Genes Immun; 2008 Dec; 9(8):668-79. PubMed ID: 18769441
[TBL] [Abstract][Full Text] [Related]
15. Preliminary study on mouse interleukin-21 application in tumor gene therapy.
Dou J; Chen G; Wang J; Zhao F; Chen J; Fang X; Tang Q; Chu L
Cell Mol Immunol; 2004 Dec; 1(6):461-6. PubMed ID: 16293216
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R
Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652
[TBL] [Abstract][Full Text] [Related]
17. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
Wu PW; Li J; Kodangattil SR; Luxenberg DP; Bennett F; Martino M; Collins M; Dunussi-Joannopoulos K; Gill DS; Wolfman NM; Fouser LA
J Mol Biol; 2008 Oct; 382(5):1168-83. PubMed ID: 18675824
[TBL] [Abstract][Full Text] [Related]
18. Cloning, heterologous expression and characterization of murine interleukin 1 receptor antagonist protein.
Shuck ME; Eessalu TE; Tracey DE; Bienkowski MJ
Eur J Immunol; 1991 Nov; 21(11):2775-80. PubMed ID: 1834470
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the disulfide bonds of recombinant murine interleukin-6 induces formation of a partially unfolded state.
Zhang JG; Matthews JM; Ward LD; Simpson RJ
Biochemistry; 1997 Mar; 36(9):2380-9. PubMed ID: 9054543
[TBL] [Abstract][Full Text] [Related]
20. Purification of the murine interleukin 3 receptor.
Mui AL; Kay RJ; Humphries RK; Krystal G
J Biol Chem; 1992 Aug; 267(23):16523-30. PubMed ID: 1644833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
